Hilleröd, Denmark

Ulla Hoeck


 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 109(Granted Patents)


Location History:

  • Hilleröd, DK (2002 - 2004)
  • Hillerod, DK (2003 - 2006)

Company Filing History:


Years Active: 2002-2006

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ulla Hoeck: Innovator in Pharmaceutical Formulations

Introduction

Ulla Hoeck is a notable inventor based in Hilleröd, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating overactive bladder conditions. With a total of 5 patents to her name, Hoeck's work has had a meaningful impact on patient care.

Latest Patents

One of Hoeck's latest patents is focused on transdermally administered tolterodine as an anti-muscarinic agent for the treatment of overactive bladder. This invention includes a set of formulations containing tolterodine and its derivatives, designed for various modes of administration, including transdermal and oral routes. The goal is to effectively manage symptoms associated with overactive bladder. Another significant patent involves a therapeutic formulation for administering tolterodine with controlled release. This method aims to maintain a consistent serum level of the active ingredient for at least 24 hours, providing stable treatment for patients with unstable or overactive urinary bladders.

Career Highlights

Throughout her career, Ulla Hoeck has worked with prominent companies in the pharmaceutical industry, including Pharmacia AB and Pharmacia & Upjohn AB. Her expertise in drug formulation and delivery systems has positioned her as a key player in the development of innovative treatments.

Collaborations

Hoeck has collaborated with several professionals in her field, including Helle Kristensen and Lene Orup Jacobsen. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Ulla Hoeck's contributions to pharmaceutical innovations, particularly in the treatment of overactive bladder, highlight her role as a leading inventor in the industry. Her patents reflect a commitment to improving patient outcomes through effective drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…